In Houston, news outlets report that MD Anderson Cancer Center was cited for serious deficiencies and the potential for patient harm, following inspections by officials from the federal Centers for Medicare and Medicaid Services (CMS) and the Texas Department of State Health Services. After an adverse patient event involving transfusion services that occurred in December, 2018, the hospital notified CMS. The inspections resulted from that notice. The Houston Chronicle reported, “The state and federal investigations revealed serious problems related to nursing care, laboratory services, patient rights, quality assurance and performance issues, and institutional oversight.” THE DARK REPORT will provide additional information about this ongoing story in future issues.
ACCUMEN ACQUIRES HALFPENNY
On June 17, Accumen Inc. of San Diego, announced the acquisition of Halfpenny Technologies Inc., of Blue Bell, Pa. Halfpenny provides a range of connectivity and other services for clinical laboratories, physicians, hospitals, health insurers, and others. Halfpenny was founded in 2000 by Charles Halfpenny, who is expected to continue with the company following its acquisition by Accumen.
- LabCorp of Burlington, N.C., announced that David P. King would retire on Nov. 1 from his current role as President and CEO. He will continue to serve as Executive Chairman of LabCorp’s Board of Directors. Before joining LabCorp in 2001, King was an attorney with Hogan & Hartson and an Assistant U.S. Attorney with the Department of Justice.
- Adam H. Schechter will become LabCorp’s new President and CEO, effective Nov. 1. Schechter has served on LabCorp’s Board of Directors since 2013. He currently holds a senior executive position at Merck & Co., where he has worked for the past 30 years.
- Veravas, Inc., of Charleston, S.C., named Carmen Wiley, PhD, as its Chief Clinical Officer. Wiley is currently President of the American Association of Clinical Chemistry. She has held positions at Roche Diagnostics, PAML, and Marshfield Clinic.
- Puneet Sarin is the new Worldwide President for BD Biosciences, effective June 17. He formerly worked at Beckman Coulter, Leica Biosystems, and GE Healthcare.
That’s all the insider intelligence for this report.
Look for the next briefing on Monday, July 22, 2019.
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know about …
…how use of a text-based appointment reminder system cut patient no-show rates by one-third at California’s largest physician-owned medical practice in Riverside. Use of text reminders could increase the number of patients with a test request who come to patient service centers to provide lab specimens.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.